Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.
Institute of Human Genetics, Technische Universität München, Munich, Germany.
Clin Genet. 2018 Mar;93(3):603-612. doi: 10.1111/cge.13124. Epub 2018 Jan 24.
Parkinson's disease (PD) is a genetically heterogeneous disorder and new putative disease genes are discovered constantly. Therefore, whole-exome sequencing could be an efficient approach to genetic testing in PD. To evaluate its performance in early-onset sporadic PD, we performed diagnostic exome sequencing in 80 individuals with manifestation of PD symptoms at age 40 or earlier and a negative family history of PD. Variants in validated and candidate disease genes and risk factors for PD and atypical Parkinson syndromes were annotated, followed by further analysis for selected variants. We detected pathogenic variants in Mendelian genes in 6.25% of cases and high-impact risk factor variants in GBA in 5% of cases, resulting in overall maximum diagnostic yield of 11.25%. One individual was compound heterozygous for variants affecting canonical splice sites in VPS13C, confirming the causal role of protein-truncating variants in this gene linked to autosomal-recessive early-onset PD. Despite the low diagnostic yield of exome sequencing in sporadic early-onset PD, the confirmation of the recently discovered VPS13C gene highlights its advantage over using predefined gene panels.
帕金森病(PD)是一种遗传异质性疾病,新的假定疾病基因不断被发现。因此,外显子组测序可能是 PD 基因检测的一种有效方法。为了评估其在早发性散发性 PD 中的性能,我们对 80 名在 40 岁或更早出现 PD 症状且 PD 家族史阴性的个体进行了诊断性外显子组测序。验证和候选疾病基因以及 PD 和非典型帕金森综合征风险因素的变异被注释,然后对选定的变异进行进一步分析。我们在 6.25%的病例中检测到孟德尔基因的致病性变异,在 5%的病例中检测到 GBA 中的高影响风险因素变异,总诊断率最高可达 11.25%。有 1 名个体为影响 VPS13C 经典剪接位点的变异的复合杂合子,证实了与常染色体隐性早发性 PD 相关的该基因中蛋白截断变异的因果作用。尽管外显子组测序在散发性早发性 PD 中的诊断率较低,但最近发现的 VPS13C 基因的证实凸显了其优于使用预定义基因面板的优势。